The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
8X8 INC NEW | NOTE 0.500% 2/0 | 282914AB6 | 42,243 | 45,450,000 | PRN | SOLE | 45,450,000 | 0 | 0 | ||
AVAYA HLDGS CORP | NOTE 2.250% 6/1 | 05351XAB7 | 20,751 | 22,000,000 | PRN | SOLE | 22,000,000 | 0 | 0 | ||
CYTOKINETICS INC | NOTE 4.000%11/1 | 23282WAA8 | 20,057 | 9,000,000 | PRN | SOLE | 9,000,000 | 0 | 0 | ||
DOCUSIGN INC | NOTE 0.500% 9/1 | 256163AB2 | 84,509 | 27,933,000 | PRN | SOLE | 27,933,000 | 0 | 0 | ||
FIREEYE INC | NOTE 1.625% 6/0 | 31816QAD3 | 43,280 | 44,390,000 | PRN | SOLE | 44,390,000 | 0 | 0 | ||
GUIDEWIRE SOFTWARE INC | NOTE 1.250% 3/1 | 40171VAA8 | 5,718 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
INFINERA CORP | NOTE 2.125% 9/0 | 45667GAC7 | 4,186 | 4,500,000 | PRN | SOLE | 4,500,000 | 0 | 0 | ||
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 4,371 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | NOTE 2.000% 5/1 | 45845PAB4 | 9,340 | 13,246,000 | PRN | SOLE | 13,246,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | NOTE 0.750% 6/1 | 46333XAF5 | 7,747 | 7,800,000 | PRN | SOLE | 7,800,000 | 0 | 0 | ||
JAZZ INVESTMENTS I LTD | NOTE 1.500% 8/1 | 472145AD3 | 29,487 | 29,009,000 | PRN | SOLE | 29,009,000 | 0 | 0 | ||
LIGAND PHARMACEUTICALS INC | NOTE 0.750% 5/1 | 53220KAF5 | 4,093 | 4,500,000 | PRN | SOLE | 4,500,000 | 0 | 0 | ||
NEW RELIC INC | NOTE 0.500% 5/0 | 64829BAB6 | 23,055 | 24,091,000 | PRN | SOLE | 24,091,000 | 0 | 0 | ||
NUANCE COMMUNICATIONS INC | DBCV 1.000%12/1 | 67020YAK6 | 27,553 | 18,904,000 | PRN | SOLE | 18,904,000 | 0 | 0 | ||
NUTANIX INC | NOTE 1/1 | 67059NAB4 | 37,631 | 39,969,000 | PRN | SOLE | 39,969,000 | 0 | 0 | ||
OMEROS CORP | NOTE 5.250% 2/1 | 682143AG7 | 2,941 | 3,500,000 | PRN | SOLE | 3,500,000 | 0 | 0 | ||
OMEROS CORP | NOTE 6.250%11/1 | 682143AE2 | 8,648 | 9,200,000 | PRN | SOLE | 9,200,000 | 0 | 0 | ||
OPKO HEALTH INC | NOTE 4.500% 2/1 | 68375NAD5 | 7,096 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | NOTE 3.000% 8/1 | 69366JAB7 | 9,674 | 8,500,000 | PRN | SOLE | 8,500,000 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 3,807 | 4,625,000 | PRN | SOLE | 4,625,000 | 0 | 0 | ||
RAMBUS INC DEL | NOTE 1.375% 2/0 | 750917AG1 | 14,140 | 13,500,000 | PRN | SOLE | 13,500,000 | 0 | 0 | ||
RAPID7 INC | NOTE 1.250% 8/0 | 753422AB0 | 13,271 | 8,500,000 | PRN | SOLE | 8,500,000 | 0 | 0 | ||
RETROPHIN INC | NOTE 2.500% 9/1 | 761299AB2 | 6,867 | 7,973,000 | PRN | SOLE | 7,973,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | DBCV 1.500%11/1 | 803607AB6 | 7,517 | 3,625,000 | PRN | SOLE | 3,625,000 | 0 | 0 | ||
SUPERNUS PHARMACEUTICALS INC | NOTE 0.625% 4/0 | 868459AD0 | 38,713 | 41,818,000 | PRN | SOLE | 41,818,000 | 0 | 0 | ||
SYNAPTICS INC | NOTE 0.500% 6/1 | 87157DAD1 | 31,095 | 25,000,000 | PRN | SOLE | 25,000,000 | 0 | 0 | ||
TERADYNE INC | NOTE 1.250%12/1 | 880770AG7 | 77,811 | 30,439,000 | PRN | SOLE | 30,439,000 | 0 | 0 | ||
TESLA INC | NOTE 2.000% 5/1 | 88160RAG6 | 145,057 | 20,962,000 | PRN | SOLE | 20,962,000 | 0 | 0 | ||
THERAVANCE INC | NOTE 2.125% 1/1 | 88338TAB0 | 5,002 | 5,200,000 | PRN | SOLE | 5,200,000 | 0 | 0 | ||
VERINT SYS INC | NOTE 1.500% 6/0 | 92343XAA8 | 39,302 | 38,646,000 | PRN | SOLE | 38,646,000 | 0 | 0 | ||
VONAGE HLDGS CORP | NOTE 1.750% 6/0 | 92886TAJ1 | 773 | 800,000 | PRN | SOLE | 800,000 | 0 | 0 | ||
WAYFAIR INC | NOTE 1.125%11/0 | 94419LAD3 | 41,495 | 16,125,000 | PRN | SOLE | 16,125,000 | 0 | 0 |